Abstract:Genetic engineering is one of the most advanced technologies in the world and can bring vast profits to developers by patenting resultant achievements. But genetic engineering must be based on original genetic materials. For obtaining such materials, developers travel around the world, especially to genetically rich areas in developing countries, to prospect for valuable genetic resources and bring back for research and patent derivate products. However a lot of disputes have arisen from such patents, such as the Enola patent dispute on Mexican traditional crop mayocoba bean and the patent dispute on sacred plant Ayahuasca between people and one U.S. Company. Indigenous people, who live in the origin areas of genetic resources for a long history, have established traditional and cultural genuine relation with some living species. These disputes revealed that some genetic engineering exploitation and patents based on certain species may be severely offensive against indigenous peoples spiritual, religious, or cultural traditions. Although genetic engineering achievements patentability has been argued for a long time, the TRIPs Agreement requirement and the worlds legislation trend, either in developed countries such as the U.S., European Union or in developing countries such as China, have indicated that genetic engineering products and processes are legitimately patentable. But some loophole exists in the patent acquisition procedure of current legislation, which allows such offensive patents to be granted. To prevent such offensive patents, one prior consents solution is proposed in this article, which requires genetic engineering developers to obtain prior consents from origin countries of genetic resources before they exploit these resources and patent derivate achievements. This solution is based on the Convention on Biological Diversity, which affirmed countrys sovereignty over their genetic resources and allowed countries to regulate and manage genetic resources in their territory. The Convention on Biological Diversity does not conflict with IPR legislation, in particular the TRIPs Agreement and the obligations under both treaties should be respected. The implementation of this proposed solution is based on the establishment of national genetic resources authority, which generally manages its countrys genetic resources and works as indigenous peoples representative with the authorization of state government. This solution should be implemented in three levels: domestically, transnationally and globally. Therefore, offensive genetic engineering patents could be prevented both by such authoritys examination and granting prior consents before developers access to genetic resources and by national patent administrations examination on prior consents proof from origin countrys authority before granting patents.

Teaming Up? China, India and Brazil and the Issue of Benefit-Sharing from Genetic Resource Use

Research on Access and Benefit-Sharing Regimes for Agricultural Genetic Resources in India

Genomic Data as a National Strategic Resource: Implications for the Genomic Commons and International Data Sharing for Biomedical Research and Innovation

Research on Intellectual Property Right Protection of Genetic Resources in China Under Benefit-Sharing

Prior Consents: Preventing Offensive Genetic Engineering Patents Against Indigenous People's Rights

Indigenous peoples and local communities as partners in the sequencing of global eukaryotic biodiversity

Why community consultation matters in genomic research benefit-sharing models

Global biodiversity research tied up by juridical interpretations of access and benefit sharing

Engaging Experts in Global Biotech Governance: What Influences Their Judgement on Value-Laden Challenges?

A Regional Review of Genetic Resource Access and Benefit Sharing – Key Issues and Research Gaps

From global bioethics to ethical governance of biomedical research collaborations.

Critical Review of the Increasing Complexity of Access and Benefit-Sharing Policies of Genetic Resources for Genebank Curators and Plant Breeders-A Public and Private Sector Perspective

"Harnessing genomics to improve health in India" - an executive course to support genomics policy

The ethics weathervane

Juridical and sociocultural problems on the definition of a law concerning property, usage and access to genetic resources in Colombia

Legal and economic perspectives on fair and equitable benefit sharing in the Nagoya Protocol

Countermeasure Analysts on Conflicts Between the Protection of Genetic Resources Diversity and Intellectual Property on Biological Technique

The emerging international regulatory framework for biotechnology

25 years after the `Rio Convention'--Lessons learned in the context of sustainable development and protecting indigenous and local knowledge

China's "Gene War of the Century" and Its Aftermath: The Contest Goes On

Regulatory Barriers to US-China Collaboration for Generative AI Development in Genomic Research